Hedge Funds Are Selling Ionis Pharmaceuticals, Inc. (IONS)
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Posts Tagged ‘NASDAQ:IONS’
10 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 10 best pharmaceutical stocks to buy according to Cathie Wood.
Hedge Funds Dipping Their Toes Into Ionis Pharmaceuticals, Inc. (IONS)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Did Hedge Funds Make The Right Call On Ionis Pharmaceuticals, Inc. (IONS) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Aren’t Crazy About Ionis Pharmaceuticals, Inc. (IONS) Anymore
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Hedge Funds Aren’t Done Buying Ionis Pharmaceuticals, Inc. (IONS)
We hate to say this but, we told you so.
How Did Ionis Pharmaceuticals, Inc. (IONS) Compare Against Top Hedge Fund Stocks in 2019?
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Hedge Funds Have Never Been This Bullish On Ionis Pharmaceuticals, Inc. (IONS)
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Is Ionis Pharmaceuticals, Inc. (IONS) A Good Stock To Buy?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Hedge Fund and Insider Trading News: Stanley Druckenmiller, Whitney Tilson, Perceptive Advisors, Bank of New York Mellon Corp (BK), Ionis Pharmaceuticals Inc (IONS), Schlumberger Limited. (SLB), and More
Billionaire hedge fund manager Stanley Druckenmiller on Tuesday warned that the budget deal struck between President Donald Trump and congressional leaders earlier this week will...
Hedge Funds Dropped The Ball On Ionis Pharmaceuticals, Inc. (IONS)?
Is Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Should You Buy Ionis Pharmaceuticals, Inc. (IONS)?
Is Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Here’s What You Need To Know About The Financial Markets Today
"Stocks fell on Thursday after the U.S. dropped "the mother of all bombs" in Afghanistan while bank stocks dropped despite strong earnings from JPMorgan Chase and Citigroup.
Is Ionis Pharmaceuticals Inc (IONS) Going to Burn These Hedge Funds?
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
Biotech Gainers On Tuesday: Amicus Therapeutics, Inc. (FOLD) And Ionis Pharmaceuticals Inc (IONS)
While wider markets turn there focus to the US elections, the biotech space is alive and well, and after a tough end to last week, a number of companies have enjoyed gains throughout...
Twitter, Ionis, Biogen, and More: Here’s Why These Five Stocks Are Making Headlines
Wall Street is in bull mode today as the Dow Jones index is up by over 250 points, and the Nasdaq and S&P are each more than 1.7% in the green.
A Closer Look at Five Stocks on the Move on Monday
Among the stocks registering significant moves are Whiting Petroleum Corp (NYSE:WLL), Ionis Pharmaceuticals Inc (NASDAQ:IONS), TOP SHIPS Inc (NASDAQ:TOPS), MeetMe Inc (NASDAQ:...
Ionis Pharmaceuticals Inc (IONS) Plunges After GSK Foregos Phase 3 Study of TTRRx
Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares have plunged by 35% this morning after GlaxoSmithKline (NYSE:GSK), which has an option to exclusively license IONIS-TTRRx, decided...
Here’s What’s Causing These Stocks To Move Sharply On Thursday
Although it isn't quite earnings season yet, volatility never sleeps. Investors and traders will always buy and sell on meaningful news and stocks will always move.
